ArticleVaccine: X2022

COVID-19 site readiness initiative: Building clinical trial capacity for vaccine efficacy trials in Latin America in response to the pandemic.

Sue Ann Costa Clemens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.